Abstract: Identifying the diff erentially expressed miRNAs in cleft palate, in order to study the molecular mechanism in the development and progress of cleft palate. C57BL/6J mice were used to establish the RA induced cleft palate mouse model. Nine pairs of tissues were obtained on embryonic day 15.5 (E15.5). Total RNA was extracted and miRNAs microarray chip was used to screen the miRNAs. Real-time quantitative PCR (RT-qPCR) was used to verify the miRNAs microarray chip results. Cleft palate related genes targeted by the miRNAs were predicted by TargetScan and miRTarBase, and functional annotation clustering of Gene Ontology (GO) term and KEGG signaling pathways in DAVID were used to analysis these target genes. 1265 miRNAs were identifi ed in cleft palate, and among them 31 were diff erentially expressed (p < 0.01, fold change > 1.5), including 17 up-regulated and 14 down-regulated miRNAs in cleft palate. 7 up-regulated miRNAs (mmu-miR181a-5p, mmu-miR-410-3p, mmu-miR-3960, mmu-miR-1224-5p, mmu-miR-3970, mmu-let-7e-5p and mmu-miR-1907) and 3 down-regulated miRNAs (mmu-miR-140-3p, mmu-miR-351-5p and mmu-miR-503-5p) were validated by RT-qPCR, and mmumiR-181a-5p and mmu-miR-410-3p were in concordance with those of miRNAs microarray chip detection. 484 target genes were predicted and proven by TargetScan and miRTarBase. GO term showed that RA-induced cleft palate was associated with enrichments in miRNAs involved in embryo development, osteoblast diff erentiation and so on. KEGG signaling pathways analysis indicated that the diff erentially expressed miRNAs were involved in MAPK, TGFβ and WNT signaling pathways. 10 diff erentially expressed miRNAs in cleft palate have been identifi ed. These miRNAs and their target genes may become new therapeutic targets for cleft palate.
Introduction
Cleft palate, a kind of common human congenital developmental deformities of oral and maxillofacial region, with a prevalence ranging from 1/1000 to 1/700, roots in genetic and environmental disturbances in the development of palate. The formation process of the secondary palatal development, including growth of the palatal shelves, elevation of the palatal shelves, fusion between paired palatal shelves and the disappearance of the midline epithelial seam, is regulated precisely. Disruption at any stage of these steps, involving in growth, elevation or fusion, genetically or environmentally, can cause cleft palate 1) . This malformation can occur in a non-syndromic form or a syndromic form in conjunction with recognized Mendelian or teratogenic malformations 2) .
Although several genetic and environmental factors have been reported for this disorder, the biological mechanism remains intricate 3) . The process of embryonic palatal development in mice is coordinated with the one in mammals temporally and spatially. At embryonic days 12.5 (E12.5) in mice, the palatal shelves root in the maxillary processes as they arise in humans at gestational weeks 6 (GW6), and then grow vertically on both sides of the tongue. At the end of E13.5 (GW8), the palatal shelves elevate to horizon above the tongue. At E14.5 (GW10), the medial edge epithelium (MEE) of the palatal shelves begins to contact and adhere between the paired shelves. The adhesive palatal shelves will form a midline epithelial seam (MES). Then fusion is accomplished with mesenchymal confl uence by E15.5 (GW12) after the MES rapidly disappears from the midline 4) . Retinoic acid (RA) -a derivative of vitamin A -is the most active compound among retinoids biologically, and it plays important roles in a variety of biological processes, such as cell proliferation and diff erentiation, regulating morphogenesis of embryonic development, and extracellular matrix production 5, 6) . Also, vitamin A and its metabolites (retinoids) are necessary in embryonic development. However, as a medicine for the treatment of cancers and other diseases, RA is a potent teratogen. Excess RA will disrupt the normal development and give rise to the abnormalities of development both in humans and rodents 7, 8) .
miRNAs are a class of highly conserved, approximately 21-25 nucleotides long noncoding RNA molecules that can regulate gene expression at the posttranscriptional level by either degradation or translational repression of a target mRNA 9) . A number of miRNAs have been found in kinds of species and regarded as powerful regulators of gene expression and cellular phenotype. miRNAs are initially transcribed as primary miRNA (pri-miRNA): the pri-miRNA is cleaved in the nucleus by the RNase III enzyme Dicer to produce an 70-nt long precursor miRNA (pre-miRNA) which has a short stem-loop structure 10) .
The pre-miRNA is further cleaved by another RNase III enzyme Dicer to produce the mature miRNA 11) . The mature miRNA then binds to the RNA-induced silencing complex (RISC), which contains multiple proteins, guiding the RISC interaction with target mRNA sequences, most favorably at the 3'untranslated region (3'UTR), suppressing the process of translation and/or causing the degradation of the targeted mRNA 9) .
Growing evidence has suggested that miRNAs participate in a series of biological processes such as cell proliferation, apoptosis, immune response, as well as many diseases 12, 13) .
We used miRNAs microarray chip technology to identify the differentially expressed miRNAs in cleft palate compared with the normal palate tissues in this study, RT-qPCR to verify the accuracy of the miRNAs microarray chip results, TargetScan and miRTarBase to predict and prove the target genes of the differentially expressed miRNAs, and DAVID to analysis the target genes in order to study the molecular mechanism in the development and progress of cleft palate.
Materials and Methods

Ethics statement
The 
Cleft Palate Mouse Model
Female C57BL/6J mice (10-12-week-old) (Specific pathogen free animal, SPF) were obtained from Laboratory Animal Center of Dalian Medical University and maintained in a specifi c pathogen free facility at the Laboratory Animal Center of Dalian Medical University. They were used to establish the RA (Sigma Aldrich, St. Louis, USA) induced cleft palate mouse model, in which the pregnant mice (E0 morning vaginal plug was found) were given a single dose of RA at 100 mg/kg body weight on embryonic day 10.5 (E10.5) respectively. RA was suspended in 0.8 ml corn oil (Yihai kerry food marketing Co. Ltd., Shenzhen, China), and the suspension mixed vigorously to obtain a uniform suspension. The pregnant mice were dosed with 0.2 ml of suspension by gavage, and the control animals were dosed with the same volume of corn oil without RA. Nine pairs of cleft palate and the normal palate tissues were obtained on embryonic day 15.5 (E15.5), saved in 200 µl RNAlater (obtained from LC SCIENCES for free) at 4℃ overnight and then stored at -80℃.
miRNAs microarray chip
Total RNA was isolated from palate samples of mouse embryo collected on E15.5. The RNA was used to determine the expression of miRNA with a μParafl o TM mouse MicroRNA microarray, Array 19.0 (LC Sciences, Houston, USA). By adding a poly (A) tail on the 3' end with poly (A) polymerase, total RNA (6 μg/sample) was extended, and then an oligonucleotide tag was ligated to the poly (A) tail for fluorescent dye staining subsequently. The prepared RNA was hybridized to a μParaflo microfluidic chip by incubating overnight under the reaction conditions which were controlled with a micro-circulation pump. With photogenerated reagent chemistry, the detection probes were synthesized in situ. After RNA hybridization, the Cy3 dye bound to the oligo tag for staining through the microfluidic chip. Fluorescence images were acquired with a laser scanner (GenePix 4000B, Molecular Device, California, USA) and digitized with Array-Pro image analysis software (Media Cybernetics, Maryland, USA).
RT-qPCR analysis for miRNAs expression
Expression levels of mmu-miR-181a-5p, mmu-miR-410-3p, mmumiR-3960, mmu-miR-1224-5p, mmu-miR-3970, mmu-let-7e-5p, mmumiR-1907, mmu-miR-140-3p, mmu-miR-351-5p and mmu-miR-503-5p were validated using RT-qPCR. The forward and reverse primers were designed by Ribobio. Total RNA was extracted from tissues using RNAlater (obtained from LC SCIENCES for free). A cDNA pool of miRNAs was synthesized by PrimeScript ® RT reagent Kit (TaKaRa, Dalian, China) according to the manufacturer's protocol. RT-qPCR was performed using a SYBR ® Premix Ex TaqTM II (Perfect Real Time) (TaKaRa, Dalian, China). The reactions were incubated in a 96-well optical plate at 95℃ for 10 min, followed by 45 cycles at 95℃ for 15 sec and 60℃ for 1 min. Expression analysis was performed in triplicate for each sample. U6 level was used as internal control.
Target genes prediction, functional annotation clustering of GO term and KEGG signaling pathway analysis The prediction of miRNAs target genes is a necessary step in understanding the functions of miRNAs. To further analyze the functions of the differentially expressed miRNAs, we used TargetScan (http:// www.targetscan.org/) 14, 15) and miRTarBase (http://mirtarbase.mbc.
nctu.edu.tw/) 16, 17) to predict their common target genes. To evaluate the target genes for all single miRNAs, we searched for significantly over-represented GO terms (p < 0.01) using DAVID Bioinformatics Database (http://david.abcc.ncifcrf.gov/) among all the target genes for the diff erentially expressed miRNAs respectively 18, 19) . In order to identify the molecular signaling pathways potentially altered by the expression of multiple miRNAs, we used the DAVID Bioinformatics Database. The database performed an enrichment analysis of multiple miRNAs target genes comparing each set of miRNAs targets to all known KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways.
Statistical analysis
For statistical analysis, data were analyzed using the SPSS 17.0 (IBM, New York, USA). The statistical significance of difference between groups was determined by Student's t-test. Results were considered statistically signifi cant if the p-value was less than 0.01 (p < 0.01).
Results
miRNAs expression profiles of cleft palate induced by RA in mouse model
The miRNAs microarray chip differential analysis resulted in 31 differentially expressed miRNAs (p < 0.01, fold change > 1.5) which were signifi cantly expressed in the palate of RA-treated mice compared with controls are shown in Table 1 and Table 2 , and the heatmap of diff erentially expressed miRNAs is plotted and shown in Fig. 1 .
Identifi cation of the diff erentially expressed miRNAs in cleft palate
In order to verify the results of the miRNAs microarray chip, we chose these diff erentially expressed miRNAs to be evaluated in matched pairs of cleft palate and the normal palate tissues using RT-qPCR. Of these, 7 up-regulated miRNAs (mmu-miR-181a-5p, mmu-miR-410-3p, mmumiR-3960, mmu-miR-1224-5p, mmu-miR-3970, mmu-let-7e-5p and mmumiR-1907) and 3 down-regulated miRNAs (mmu-miR-140-3p, mmumiR-351-5p and mmu-miR-503-5p) were validated by RT-qPCR, and mmu-miR-181a-5p and mmu-miR-410-3p were in concordance with the results of the miRNAs microarray chip data in RA-treated palate tissues compared with controls. RT-qPCR validated the miRNAs microarray chip analysis (Fig. 2) .
Target genes prediction of the diff erentially expressed miRNAs
In-depth knowledge of the targeted relationship between the NP1 NP2 NP3 RP4 RP5 RP6 Sample 245 expression-level mmu-miR-351-5p mmu-miR-495-3p mmu-miR-128-3p mmu-miR-127-3p mmu-miR-378d mmu-miR-441-5p mmu-miR-140-3p mmu-miR-378b mmu-miR-410-3p mmu-miR-378a-3p mmu-miR-145a-5p mmu-miR-92a-3p mmu-miR-6239 mmu-miR-503-5p mmu-miR-186-5p mmu-miR-27b-3p mmu-miR-181a-5p mmu-miR-1195 mmu-miR-1224-5p mmu-miR-149-3p mmu-miR-3473b mmu-miR-3473e mmu-miR-466m-5p mmu-let-7e-5p mmu-miR-2861 mmu-miR-3960 mmu-miR-1907 mmu-miR-5115 mmu-miR-3963 mmu-miR-762 mmu-miR-3970 -1 0 1
Figure 2. Validation of miRNAs by RT-qPCR
The expression levels of 10 diff erentially expressed miRNAs were detected by RT-qPCR. The expression levels of 2 diff erentially expressed miRNAs were in concordance with the normalized miRNAs microarray chip data. Every group was replicated three times using independently collected samples. Figure 4 . KEGG signaling pathway analysis for target genes of diff erentially expressed miRNAs The x-axis indicates the enrichment signifi cance and expressed as the -log 10 (p-value), and the y-axis indicates the KEGG signaling pathway names. 0 1 2 3 4 -log 10 (p-value) diff erentially expressed miRNAs and genes, TargetScan and miRTarBase was used to predict the target genes of the differentially expressed miRNAs. As expected, these miRNAs could potentially regulate several hundred target genes. Finally, we found out the predicted and proved 484 target genes.
KEGG
Functional annotation clustering of GO term
In order to analyze the relationship between expression patterns and functional implications of the target genes, we applied DAVID to classify the target genes of the diff erentially expressed miRNAs into a couple of function categories. GOTERM_BP_FAT, GOTERM_CC_ MAPK signaling pathway TGF-beta signaling pathway Axon guidance Chronic myeloid leukemia Glutamatergic synapse Neurotrophin signaling pathway Long-term potentiation GnRH signaling pathway Wnt signaling pathway FAT, GOTERM_MF_FAT and SP_PIR_KEYWORDS in Gene Ontology were used to enrich the clusters of related functional terms for all the target genes. We received 19 annotation clusters from the target genes of the diff erentially expressed miRNAs with the enriched score greater than 3.0 (p < 0.01). Functional annotation clustering analysis of GO term showed that RA-induced cleft palate was associated with enrichments in miRNAs involved in embryo development, cell migration, osteoblast diff erentiation and so on (Fig. 3) .
KEGG signaling pathway analysis
After analyzing the functional annotation clustering of GO term, we performed the signaling pathway analysis with the target genes of the differentially expressed miRNAs between RA-treated and control palate tissues. KEGG_PATHWAY in Pathways was used to analyze the signaling pathways with the threshold of p-value less than 0.01. The result indicated that the diff erentially expressed miRNAs between RAinduced cleft palate and control involving in mitogen activated protein kinase (MAPK) signaling, transforming growth factor-beta (TGFβ) signaling and WNT/β-Catenin signaling pathways were mainly associated with cleft palate (Fig. 4) .
Discussion
Cleft palate and other congenital developmental deformities of oral and maxillofacial region are common in humans and have complex cellular and genetic etiologies. In vertebrates, the palate separates the nasal and oral cavities and is generated through an intricate series of morphogenic events that include early neural crest cell migration and cell-cell signaling during the formation of facial prominences, as well as later generation and fusion of palatal process 20) . Palate development is a complex mechanism that involves elevation, contact, and fusion of palatal process 21) . Therefore, correct gene expression is necessary for proper palate development in both palatal epithelium and mesenchyme 22, 23, 24) . miRNAs microarray chip, as a kind of rapid and effi cient method to analyze the miRNAs expression profi les, has been widely used to identify the differentially expressed miRNAs in tumor 25, 26) . However, there is no report about the miRNAs expression profiles in cleft palate so far. Therefore, we used miRNAs microarray chip technology to identify the diff erentially expressed miRNAs involved in cleft palate induced by RA in mouse model. Combined with RT-qPCR, we verifi ed 7 up-regulated miRNAs (mmu-miR-181a-5p, mmu-miR-410-3p, mmu-miR-3960, mmumiR-1224-5p, mmu-miR-3970, mmu-let-7e-5p and mmu-miR-1907) and 3 down-regulated miRNAs (mmu-miR-140-3p, mmu-miR-351-5p and mmumiR-503-5p) (p < 0.01, fold change > 1.5) in RA-treated palate tissues compared with control. RA acts as a pivotal role in embryonic development, cell proliferation and differentiation and extracellular matrix production 5, 6, 7) . RA could inhibit the growth of MEPM (mouse embryonic palatal mesenchymal) cells in a dose-dependent method by leading to apoptosis. In the cell cycle, RA could bring about a G1 block with a decrease in the proportion of cells in S phase and an increase in the proportion of cells in G0/G1 phase by inhibiting expression of cyclins D and E at the protein level 27) .
In mouse fetuses, cleft palate is one of the mainly malformations induced by RA. In RA-induced cleft palate of mouse fetuses, we can see the palatal shelves are still growing vertically on both sides of the tongue. Cell proliferation appeared in epithelium and mesenchyme, and gradually reduced from E13.5 to E15.5. RA didn't influence the proliferation of palatal epithelium. However, cell apoptosis appeared at a specific time and location, and RA could infl uence the apoptosis of the specifi c epithelium at E13.5 and E14.5, which was in step with the time of downregulated Wnt/β-catenin signaling. As reported, the canonical Wnt/ β-catenin signaling pathway was completely inhibited by RA at E13.5 and E14.5. Wnt/β-catenin signaling pathway was a very important target of RA on account of blocking Wnt/β-catenin signaling almost completely replicated the action of RA. RA could increase Gsk-3β by Wnt/β-catenin signaling pathway to modulate the development of palate. Furthermore, RAR (RA receptor) is essential for RA to play its biological actions 28, 29) . It has been demonstrated that WNT genes are associated with cleft lip and palate. Wnt3a, Wnt5a and Wnt11 are differentially expressed in non-syndromic cleft lip with or without cleft palate significantly 30) .
Autosomal-recessive tetra-amelia with cleft lip and palate is based on mutations in Wnt3 31) .
TGFβ (transforming growth factor-β) family members include TGFβ1, TGFβ2 and TGFβ3. In mammals, all the three TGFβ isoforms are exactly timing and spatial expressed during palatal development. TGFβ3 seems to act an essential role in all the three TGFβ isoforms, in which TGFβ3 gene mutations and/or deficiencies result in cleft palate both in mice 32, 33, 34) and humans 35) . There are three main types of cell surface receptor proteins in the TGFβ3 signaling system: TGFβR1, TGFβR2 and TGFβR3. When TGFβ binds to the cell surface receptor complex, they will lead to phosphorylation and activation of the Smad proteins, which is the intracellular mediators of TGFβ signaling acting as transcriptional activators of target genes 36) . In the MEPM cells, RA increased the mRNA expression and protein of TGFβ3, and functional interactions between retinoic systems and TGFβ had been found in diff erent settings. It had been reported that RA could decrease the expression of TGFβR1 and increase the expression of TGFβR2, but couldn't aff ect the expression of TGFβR3 28) .
As reported, miR-2861 accelerated osteoblast differentiation by targeting HDAC5 (histone deacetylase 5), giving rise to increased Runx2 (runt-related transcription factor 2) protein production. miR-3960, clustered with miR-2861, regulated osteoblast differentiation through a regulatory feedback loop with miR-2861. During bone morphogenic protein 2 (BMP2)-induced osteogenesis of ST2 stromal cells, miR-3960 was transcribed. Overexpression of miR-3960 could promote BMP2-induced osteoblastogenesis. Furthermore, inhibiting the expression of miR-3960 could attenuate the osteoblastogenesis. Hoxa2 (homeobox A2), which was a repressor of Runx2 expression, was verified to be a target gene of miR-3960. Overexpression of Runx2 could induce miR-3960/miR-2861 transcription, and inhibiting the expression of Runx2 could attenuate BMP2-induced miR-3960/ miR-2861 transcription 37, 38) . In this study, we speculated that the down-regulated miR-2861 attenuated the osteoblastogenesis of palate bone, which consequently induced cleft palate. SATB2 (special AT-rich sequence binding protein 2) plays important roles in development and tissue regeneration, especially in palate formation and osteoblast differentiation and so on. During osteoblastogenesis, several cytokines and growth factors regulate the expression of SATB2. Smad1/5 targets SATB2 directly and promotes its expression by BMP2/4/7 activating Smad signaling pathways. BMP2/4/7 also induces Osx and Runx2 expression resulting in SATB2 expression. Osx enhances the expression of SATB2 by binding to the SATB2 promoter directly. In skeletal development and osteoblast diff erentiation, SATB2 was thought to be an important molecular node. SATB2 can inhibit the expression of Hoxa2 so as to bring about Runx2-dependent osteoblast differentiation. SATB2, acts as a transcription factor, can promote key transcription factors and biomarkers of osteoblast differentiation. Both in a Runx2-independent and Runx2-dependent way, SATB2 can induce the expression of Osterix. It can enhance OCN expression by enhancing Runx2 and ATF4 complex, and it also can promote BSP expression by binding to the BSP promoter directly 39) . DDIT4 (the DNA-damage-inducible transcript 4), a predicted target gene of miR-181a-5p, suppresses mTOR activity through the TSC1/ TSC2 heterodimer 40, 41) . MAPK3 is also another predicted target gene of miR-181a-5p 42) . It is possible that miR-181a-5p inhibits the expression of DDIT4 and MAPK3 to participate in the process of diff erentiation by mTOR signaling pathway and MAPK/ERK signaling pathway. In this study, we identifi ed the diff erentially expressed microRNAs involved in cleft palate induced by RA in mouse model and predicted their target genes. These diff erentially expressed miRNAs may become new therapeutic targets for cleft palate. On the basis of functional annotation clustering of GO term and KEGG signaling pathway analysis of these differentially expressed microRNAs simultaneously, it helps study the molecular mechanism in the development and progress of cleft palate.
